Overall, based on previous articles and our results, we believe that in terms of genomic characteristics, CRC samples with BRAF and RNF43 co-mutation tend to have better prognostic genomic features, and RNF43 mutation may be possible to identify genomic features in BRAF mutant CRC samples. This evidence concerns the gene BRAF and colorectal carcinoma.